Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft

被引:0
|
作者
Lund, Eiliv [1 ,2 ]
Busund, Lill-Tove Rasmussen [1 ,3 ]
Thalabard, Jean-Christophe [4 ]
机构
[1] UiT Arctic Univ Norway, Tromso, Norway
[2] Canc Registry Norway, Oslo, Norway
[3] Univ Hosp North Norway, Tromso, Norway
[4] Univ Paris 05, USPC, UMR CNRS 8145, MAP5, Paris, France
关键词
Breast cancer; Theory; Semi-allograft; Integrated systems epidemiology; Parity; Immune response; Pseudo semi-allograft; NORWEGIAN WOMEN; RISK-FACTORS; PREGNANCY; CONTRACEPTIVES; MECHANISMS; REANALYSIS; TOLERANCE; CELLS;
D O I
10.1016/j.mehy.2018.08.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The theory of breast cancer as a child deficiency disease is an inversion of the current paradigm, which considers full term pregnancies to be a protective factor and uses nulliparous women as the reference group. Instead, the theory of breast cancer as a child deficiency disease says that women with the highest parity (about 20, which is the limit of human fertility) are those with the lowest risk and should be used as the reference group in risk estimations. This theory is explained biologically by converting parity from the simple value of number of children into an understanding of the long-lasting biological and immunological effects of pregnancy. These effects can be reflected, as measured by functional genomics, in gene expression of the immune cells in the blood. Each pregnancy represents a unique fetus or semi-allograft, which provokes the creation and deposit of memory cell clones in the mother. Gene expression levels have been found to change linearly with number of full-term pregnancies in healthy women, but not in breast cancer patients. High hormone levels are necessary for a successful pregnancy, as they modulate the immune response from adaptive to innate in order to protect the fetus (considered as a semi-allograft) from rejection. At the end of the pregnancy, hormone levels drop, and the immune system recognizes the semi-allograft, but not in time for rejection to occur before birth. High hormones levels are also classified as carcinogens illustrating that carcinogenesis in the breast could be viewed as a war or balance between later exposures to hormonal carcinogens and the protection of the immune system. We propose that breast tumors are pseudo semi-allografts made up of transformed breast tissue cells. Assuming that the sensitivity to the exposure to increased levels of endogenous or exogenous hormones in women with breast cancer mimic those that occur in pregnancy, these breast tumor cells are protected against the body's immune reaction, just as the fetus is during pregnancy. However, with more pregnancies, the potential to eradicate the pseudo semi-allograft might increase due to enhanced immune surveillance. The theory of breast cancer as a child deficiency disease proposes that the protective effect of pregnancy on breast cancer incidence via the immune system is independent of other risk factors.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [1] Mechanisms of disease: Estrogen carcinogenesis in breast cancer
    Yager, JD
    Davidson, NE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03): : 270 - 282
  • [2] Estrogen Carcinogenesis in Breast Cancer
    Germain, Doris
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (03) : 473 - +
  • [3] Hormones and carcinogenesis in breast cancer
    Falkenberg, M.
    Kiesel, L.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2013, 11 (03): : 225 - 228
  • [4] Rethinking the development of breast cancer
    Schehr, RS
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (06) : 517 - 518
  • [5] Rethinking Breast Cancer Screening
    Harris, Russell P.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1321 - 1321
  • [6] RETHINKING BREAST CANCER TOXICOLOGY
    Kemsley, Jyllian
    [J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (10) : 40 - 41
  • [7] Rethinking the development of breast cancer
    Robert S. Schehr
    [J]. Nature Biotechnology, 1997, 15 : 517 - 518
  • [8] Aquaporins in human breast cancer: Identification and involvement in carcinogenesis of breast cancer
    Shi, Zhonghua
    Zhang, Ting
    Luo, Liang
    Zhao, Hua
    Cheng, Jing
    Xiang, Jingying
    Zhao, Chun
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (03) : 267 - 272
  • [9] Rethinking Screening for Breast Cancer and Prostate Cancer
    Esserman, Laura
    Shieh, Yiwey
    Thompson, Ian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (15): : 1685 - 1692
  • [10] Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms
    Kravchenko, Julia
    Akushevich, Igor
    Seewaldt, Victoria L.
    Abernethy, Amy P.
    Lyerly, H. Kim
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 483 - 493